PMEF
KYNB

Point72 Middle East FZE’s Kyntra Bio KYNB Stock Holding History

Point72 Middle East FZE’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,662
Closed -$36.8K – 497
2023
Q4 		$36.8K Sell
1,662
-12,033
-88% -$182K ﹤0.01% 1312
2023
Q3 		$295K Buy
13,695
+9,205
+205% +$361K 0.01% 936
2023
Q2 		$303K Buy
+4,490
New +$1.86M 0.01% 929

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Middle East FZE's KYNB Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 1,662 shares — an estimated $36.8K sold.

Point72 Middle East FZE first reported a position in KYNB in Q2 2023 and held it in 3 quarters. The position peaked at $303K in Q2 2023. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,662 Kyntra Bio shares in Q1 2024, an estimated $36.8K.
  • Point72 Middle East FZE first reported a position in Kyntra Bio in Q2 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Kyntra Bio position peaked at $303K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.